Nasdaq · CIK 0001553846
RDHL RedHill Biopharma Ltd.
Insider trading from SEC Form 4. Last filing 7 d ago. Close $0.54 on Oct 9, 2026, +14% from the 52-week low and -71% from the high.
RedHill Biopharma Ltd. (RDHL) has 1 SEC Form 4 filing on file from 1 insider, the latest filed on Oct 6, 2026. In the last 90 days insiders made 0 open-market buys worth $0 and 1 open-market sell worth $1,431, net -$1,431.
1 open-market trade has been scored at RDHL. The newest: Gilead Raday (Chief Operating Officer) sold $1,431 of stock on Oct 1, 2026, filed Oct 6, 2026, scored 5 (weak).
RDHL closed at $0.54 on Oct 9, 2026, 14% above its 52-week low and 71% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at RedHill Biopharma Ltd., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 5Weak | Gilead Raday Chief Operating Officer sell | $1,431 14,310,000 shares | -7% | - |
Transactions
Every row filed, 2 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Gilead Raday Chief Operating Officer | SOpen-market sale Ordinary Shares | -14,310,000 | $0.00 | $1,431 | 176,910,000 | 7 d ago |
| Oct 1, 2026 | Gilead Raday Chief Operating Officer | MOption exercise American Depository Sharesderivative | +27,560,000 | $0.00 | $0 | 131,690,000 | 7 d ago |
Questions about RDHL
Answered from the filings on this page, as of the latest one.
Are insiders buying RDHL?
As of Oct 6, 2026, SEC Form 4 filings show 0 open-market buys worth $0 by 0 insiders and 1 open-market sell worth $1,431 by 1 insider at RedHill Biopharma Ltd. in the last 90 days, net -$1,431. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade RDHL on the open market?
Gilead Raday (Chief Operating Officer) sold $1,431 of RDHL on Oct 1, 2026 and filed the Form 4 on Oct 6, 2026. InsiderTell scored 5 (weak).
How many insiders file Form 4 at RedHill Biopharma Ltd.?
1 person has filed a Form 4 at RedHill Biopharma Ltd., among them Gilead Raday (Chief Operating Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.